Medication info

Losariton Tablet 50 mg (Losartan Potassium)

Prescription medicationTabletOralExpired
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Independent Bio Pharmaceuticals Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle
Approval status
Expired

MFDS item code 201903567 · Approved 2019.05.30

This product's status changed to Expired on 2024.05.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to up to 100 mg once daily if necessary. Nephropathy in patients with type 2 diabetes and hypertension: The usual dose is 50 mg once daily, which may be increased to up to 100 mg once daily depending on blood pressure. An initial dose of 25 mg is recommended if there is concern about an excessive reduction in blood pressure. Special patient populations: - Older adults aged 75 years or younger: No adjustment of the initial dose is necessary - Older adults aged 75 years or older: An initial dose of 25 mg once daily is recommended - Patients with renal impairment (creatinine clearance 20 ∼ 50 mL/min): No adjustment of the initial dose is necessary - Patients with renal impairment (creatinine clearance < 20 mL/min and receiving dialysis): An initial dose of 25 mg once daily is recommended - Patients with reduced effective intravascular volume: An initial dose of 25 mg once daily is recommended - Patients with hepatic impairment: Consider administering a low dose; use is contraindicated in patients with severe hepatic impairment
Child dose
Children and adolescents aged 6 years and older: - Body weight 20 kg or more and less than 50 kg: 25 mg once daily is recommended; the dose may be increased to a maximum of 50 mg once daily - Body weight 50 kg or more: 50 mg once daily is recommended; the dose may be increased to a maximum of 100 mg once daily Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Independent Bio Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This drug is used to treat hypertension. It also helps to prevent and treat kidney disease in patients with type 2 diabetes and hypertension. In other words, it effectively controls blood pressure to prevent kidney damage and contributes to maintaining health.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or the dose may be increased to up to 100 mg once daily if necessary. Nephropathy in patients with type 2 diabetes and hypertension: The usual dose is 50 mg once daily, which may be increased to up to 100 mg once daily depending on blood pressure. An initial dose of 25 mg is recommended if there is concern about an excessive reduction in blood pressure. Special patient populations: - Older adults aged 75 years or younger: No adjustment of the initial dose is necessary - Older adults aged 75 years or older: An initial dose of 25 mg once daily is recommended - Patients with renal impairment (creatinine clearance 20 ∼ 50 mL/min): No adjustment of the initial dose is necessary - Patients with renal impairment (creatinine clearance < 20 mL/min and receiving dialysis): An initial dose of 25 mg once daily is recommended - Patients with reduced effective intravascular volume: An initial dose of 25 mg once daily is recommended - Patients with hepatic impairment: Consider administering a low dose; use is contraindicated in patients with severe hepatic impairment

Child dose

Children and adolescents aged 6 years and older: - Body weight 20 kg or more and less than 50 kg: 25 mg once daily is recommended; the dose may be increased to a maximum of 50 mg once daily - Body weight 50 kg or more: 50 mg once daily is recommended; the dose may be increased to a maximum of 100 mg once daily Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This drug may affect fetal kidney development during pregnancy, and should not be taken in the second and third trimesters. It should be discontinued immediately if pregnancy is confirmed, as caution is needed to prevent serious harm to the fetus and newborn. This drug should not be administered to certain patients. For instance, individuals who are allergic to this drug or its components, pregnant women or women who may become pregnant, patients with severe liver dysfunction, patients with hereditary angioedema, and patients with primary hyperaldosteronism, among others. Patients with lactose intolerance should also avoid this drug. Elderly patients or patients with high serum potassium, weakened liver function, valvular heart disease, or cerebrovascular disease should use this drug cautiously, as there may be risks of significantly low blood pressure. This drug may cause various side effects, including muscle cramps, dizziness, back pain, and upper respiratory infections. Rarely, serious side effects such as angioedema, hepatitis, myalgia, hyperkalemia, and hypotension have been reported, so patients should consult a healthcare professional immediately if unusual symptoms occur. Patients with liver dysfunction may have elevated drug concentrations in the blood, necessitating dosage adjustments. Patients with impaired kidney function also require careful administration and should have serum potassium levels monitored regularly. This drug may interact with other medications, so it is essential to consult a healthcare provider, especially if taking potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), lithium, etc. Consumption of grapefruit juice should be avoided, as it may reduce the efficacy of this drug. Pregnant or nursing women should avoid taking this drug, and if breastfeeding, it is recommended to discontinue nursing. This drug is not to be administered to children under 6 years of age or to children and adolescents with severe impairment in kidney function. During treatment, blood pressure, kidney function, and electrolyte levels should be monitored regularly. If symptoms of hypotension or renal failure occur, healthcare personnel should be notified immediately. This drug lowers blood pressure; therefore, caution should be exercised while driving or operating machinery due to possible dizziness or drowsiness. In the event of overdose, symptoms such as hypotension and tachycardia may occur, requiring prompt emergency care. This drug is not removed by dialysis. Finally, this drug should be stored out of reach of children in a safe place, and it is advisable not to transfer it to other containers.

Side effects

  • Decreased skull formation
  • anuria
  • hypotension
  • renal failure
  • muscle cramps
  • back pain
  • limb pain
  • dizziness
  • congestion
  • upper respiratory infection
Show 131 more
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastroenteritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neuroexcitability
  • sensory abnormality
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • lethargy
  • thrombocytopenia
  • myalgia
  • weakness
  • increased creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythematous skin syndrome
  • hyperkalemia
  • hyponatremia
  • increased ALT
  • increased BUN
  • increased serum creatinine
  • decreased hemoglobin
  • decreased hematocrit
  • increased liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • atrial fibrillation
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain storage temperatures between 1 degree Celsius and 30 degrees Celsius at room temperature. This helps to preserve the drug's effectiveness for a long time.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.